Accessibility Menu
Claritev logo

Claritev(NYSE) CTEV

Market Cap$619.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-90%
5 Year-84%
1 Year-46%
1 Month+49%
$36.74
-1.42%
-0.53Today
After hours$36.49-$0.25 (-0.68%)
Claritev last closing stock price
MetricPriceDate
Last closeUSD 37.272026-08-21
Claritev stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.23%USD 38.122026-08-14
1 month+49.2%USD 24.982026-07-22
3 month+71.99%USD 21.672026-05-22
Year to date-12.82%USD 42.752025-12-31
1 year-45.72%USD 68.662025-08-21
3 year-40.65%USD 62.802023-08-22
5 year-84.39%USD 238.802021-08-20
Since inception-90.41%USD 388.802020-04-03

Claritev Financials at a Glance

Market Cap

$619.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$994.67M

Net Income (TTM)

-$283.11M

EPS (TTM)

-$17.01

P/E Ratio

-2.15

Dividend

$0.00

Beta (Volatility)

1.46 (Average)

Price

$36.74

Volume

76,191.37

Open

$37.53

Previous Close

$36.58

Daily Range

$36.29 - $38.40

52-Week Range

$11.50 - $74.07

Estimated Earnings Date

Nov 6, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Claritev

Claritev Corporation helps health insurers find billing errors and save money. It uses data to lower medical costs for employers and patients. The company manages networks to get better prices from healthcare providers.

Solutions for a Complex System

  • Claims Intelligence Solutions: Uses data and algorithms to find billing overcharges and recommends fair reimbursement rates for out-of-network care.
  • Network Solutions: Provides access to discounted rates through an independent network of healthcare providers for payers without their own contracts.
  • Payment and Revenue Integrity: Identifies and removes improper or unnecessary charges before or after claims are paid to ensure billing accuracy.
  • Data and Analytics: Applies data science to help clients optimize their benefit plan designs and improve clinical results for patients.

Navigating Change and New Directions

  • Adopted the name Claritev Corporation in February 2025 to align the brand with its focus on healthcare data and clarity.
  • Closed a major refinancing transaction on Jan. 30, 2025, to restructure its debt and issued new senior secured credit facilities.
  • Launched Vision 2030, a multiyear transformation program to modernize technology and hire specialized personnel for data-driven projects.
  • Expanded services in Data iSight and Surprise Bill Services, which drove revenue growth during the first half of 2026.

Data Insights and Network Reach

Claritev operates one of the largest independent preferred provider networks in the United States. Its revenue model aligns with client interests because fees are often linked directly to the savings the company identifies.

Recent Performance by the Numbers

  • Revenue was $502.2 million for the six-month period ended June 30, 2026, up 6.2% year over year.
  • Operating income was $30.0 million for the six-month period ended June 30, 2026, up 14.2% year over year.
  • Net loss was $132.8 million for the six-month period ended June 30, 2026, down 0.9% year over year.
  • One client accounted for 35.0% of total revenue for the three-month period ended June 30, 2026.
  • Total cash and restricted cash was $27.7 million as of June 30, 2026.

Bottom Line

Claritev has transitioned from a traditional provider network into a technology-enabled analytics firm. Its Vision 2030 initiative aims to integrate modern data science across the entire healthcare payment cycle to improve system sustainability.

AI Generated • Aug 8, 2026

Industry

Health Care Technology

Employees

3,000

CEO

Travis S. Dalton

Headquarters

McLean, VA 22102, US

CTEV Financials

Key Financial Metrics (TTM)

Gross Margin

44.27%

Operating Margin

4.91%

Net Income Margin

-28.46%

Return on Equity

139.56%

Return on Capital

1.01%

Return on Assets

-5.94%

Earnings Yield

-46.51%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$619.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

16.95M

Volume

76.19K

Avg. Volume

119.21K

Financials (TTM)

Gross Profit

$440.34M

Operating Income

$48.82M

EBITDA

$590.59M

Operating Cash Flow

$133.04M

Capital Expenditure

-$150.96M

Free Cash Flow

-$17.92M

Cash & ST Invst.

$14.37M

Total Debt

$4.62B

Claritev Performance Analysis

Claritev annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,079,716,000-3.4%
20232023-12-31USD 961,524,000-10.9%
20242024-12-31USD 930,624,000-3.2%
20252025-12-31USD 965,413,0003.7%
Claritev sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.8%
Q42025-12-310.2%
Q12026-03-31-0.8%
Q22026-06-305.2%
Claritev annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -35.87N/A
20232023-12-31USD -5.69-84.1%
20242024-12-31USD -101.921692.7%
20252025-12-31USD -17.30-83.0%
Claritev sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-11.0%
Q42025-12-31-15.4%
Q12026-03-319.6%
Q22026-06-3020.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$257.48M

+6.6%

Gross Profit

$23.41M

-87.0%

Gross Margin

9.09%

N/A

Market Cap

$619.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$206.65K

N/A

Employees

3,000

N/A

Net Income

-$59.23M

+5.5%

EBITDA

$201.98M

+56.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$14.37M

-74.5%

Total Debt

$4.62B

-0.6%

Accounts Receivable

$148.90M

+4.4%

Inventory

$0.00

N/A

Long Term Debt

$4.60B

-0.6%

Short Term Debt

$19.30M

+0.7%

Return on Assets

-5.94%

N/A

Return on Invested Capital

1.08%

N/A

Free Cash Flow

$54.59M

+49.1%

Operating Cash Flow

$92.67M

+51.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EVHEvolent Health, Inc.
$4.72-0.42%
INMDInMode Ltd.
$15.10+0.27%
SANASana Biotechnology, Inc.
$3.78-3.32%
LFMDLifeMD, Inc.
$3.14-5.14%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$208.48-0.03%
BITOProShares Trust - ProShares Bitcoin ETF
$10.63+0.02%
INTCIntel
$87.26-0.03%
IBITiShares Bitcoin Trust
$44.64+0.02%

Questions About CTEV

What is the current price of Claritev?

Claritev is trading at $36.58 per share.

What is the 52-week range for Claritev?

Over the past 52 weeks, Claritev has traded between $11.50 and $74.07.

How much debt does Claritev have?

As of the most recent reporting period, Claritev reported total debt of $4.69B.

How much cash does Claritev have on hand?

Claritev reported $27.68M in cash and cash equivalents in its most recent financial results.

What is Claritev’s dividend yield?

Claritev does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.